Sergio Sosa‐Estáni

Author

Sergio Sosa‐Estáni

Administración Nacional de Laboratorios e Institutos de Salud ORCID

Also Known As

S Sosa-Estani, S Sosa‐Estani, S. SOSA-ESTANI, S. Sosa-Estani, SERGIO SOSA-ESTANI, Sergio Sosa-Estani, Sergio Sosa‐Estani, Sergio Sosa‐Estáni, Sosa-Estani, Sergio

116

Publications

6.8K

Citations

H-Index

Concepts

All Affiliations

Administración Nacional de Laboratorios e Institutos de Salud Consejo Nacional de Investigaciones Científicas y Técnicas Instituto de Efectividad Clínica y Sanitaria Ministerio de Salud Drugs for Neglected Diseases Initiative

About

Sergio Sosa‐Estáni is an author at Administración Nacional de Laboratorios e Institutos de Salud specializing in medicine, parasitology, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	23	2K
2	Health Sciences	3	3	159
3	Education	1	1	15
4	Engineering	1	1	197
5	Natural Sciences	1	1	29

Sergio Sosa‐Estáni

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
Randomized Trial of Benznidazole for Chronic Chagas’ Cardiomyopathy Carlos A. Morillo, José Antônio Marin‐Neto, Álvaro Avezum, New England Journal of Medicine	2015	1K
Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers Carlos A. Morillo, Hetty Waskin, Sergio Sosa‐Estáni, Journal of the American College of Cardiology Eliminating ParasitesParasitic DiseaseAntiparasitic AgentMedicineParasitic Protozoa	2017	309
Towards a Paradigm Shift in the Treatment of Chronic Chagas Disease Rodolfo Viotti, Belkisyolé Alarcón de Noya, Tânia Cremonini de Araújo-Jorge, Antimicrobial Agents and Chemotherapy	2013	229
Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: The BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT) José Antônio Marin‐Neto, Anis Rassi, Carlos A. Morillo, American Heart Journal African TrypanosomiasisMedicineBenznidazole EvaluationRandomized Placebo-controlled TrialPharmacotherapy	2008	209
Analytical Validation of Quantitative Real-Time PCR Methods for Quantification of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease Patients Juan Carlos Ramı́rez, Carolina Cura, Otacílio C. Moreira, Journal of Molecular Diagnostics Analytical ValidationEngineeringParasitic ProtozoaMedicineAfrican Trypanosomiasis	2015	197
New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial Faustino Torrico, Joaquím Gascón, Fabiana Barreira, The Lancet Infectious Diseases	2021	194
Trypanocide Treatment of Women Infected with Trypanosoma cruzi and Its Effect on Preventing Congenital Chagas Diana Fabbro, Emmaría Danesi, Verónica Olivera, PLoS neglected tropical diseases Maternal ImmunizationTrypanosoma CruziParasitic DiseaseAfrican TrypanosomiasisParasitic Protozoa	2014	187
Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitemia in patients with chronic Chagas disease cardiomyopathy: A substudy from the BENEFIT trial Otacílio C. Moreira, Juan David Ramírez, Elsa Velázquez, Acta Tropica	2012	160
Characterization and Epidemiologic Subtyping of Shiga Toxin–Producing <i>Escherichia coli</i> Strains Isolated from Hemolytic Uremic Syndrome and Diarrhea Cases in Argentina M Rivas, E Miliwebsky, Isabel Chinen, Foodborne Pathogens and Disease	2006	150
Etiological treatment of young women infected with Trypanosoma cruzi, and prevention of congenital transmission Sergio Sosa‐Estáni, E. Cura, Elsa Velázquez, Revista da Sociedade Brasileira de Medicina Tropical Trypanosoma CruziParasitic DiseaseInfected ChildrenParasitic ProtozoaAfrican Trypanosomiasis	2009	108

Page 1